A detailed history of Lgt Fund Management CO Ltd. transactions in Abb Vie Inc. stock. As of the latest transaction made, Lgt Fund Management CO Ltd. holds 4,051 shares of ABBV stock, worth $725,939. This represents 0.08% of its overall portfolio holdings.

Number of Shares
4,051
Previous 2,584 56.77%
Holding current value
$725,939
Previous $443,000 80.36%
% of portfolio
0.08%
Previous 0.06%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$163.84 - $199.33 $240,353 - $292,417
1,467 Added 56.77%
4,051 $799,000
Q2 2024

Aug 07, 2024

BUY
$154.79 - $180.76 $399,977 - $467,083
2,584 New
2,584 $443,000

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $317B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Lgt Fund Management CO Ltd. Portfolio

Follow Lgt Fund Management CO Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Lgt Fund Management CO Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Lgt Fund Management CO Ltd. with notifications on news.